» Articles » PMID: 2426708

Identification and Characterization of the NMYC Gene Product in Human Neuroblastoma Cells by Monoclonal Antibodies with Defined Specificities

Overview
Specialty Science
Date 1986 Aug 1
PMID 2426708
Citations 37
Authors
Affiliations
Soon will be listed here.
Abstract

Increased N-myc (now designated NMYC in human gene nomenclature) gene expression has been detected at the transcriptional level in certain types of neoplasms. As yet, the N-myc gene product has not been identified. To detect and characterize the N-myc gene product, we have developed monoclonal antibodies against the putative N-myc gene product made in Escherichia coli as a fusion protein. The antibodies that recognize the N-myc-specific regions were selected on the basis of their reactivities to different portions of the fusion protein. These monoclonal antibodies detect a pair of closely migrating polypeptides of 60 and 63 kDa in nuclear fractions of human neuroblastoma cells. The relative levels of the polypeptides are roughly proportional to the level of N-myc transcripts present in a panel of neuroblastoma lines. These two polypeptides have a half-life of approximately equal to 35 min, and they are indistinguishable from each other by their epitopic profiles.

Citing Articles

AF1q is a universal marker of neuroblastoma that sustains N-Myc expression and drives tumorigenesis.

Oskouian B, Lee J, Asgharzadeh S, Khan R, Zhang M, Weisbrod J Oncogene. 2024; 43(16):1203-1213.

PMID: 38413795 PMC: 11014797. DOI: 10.1038/s41388-024-02980-y.


BRD4 prevents the accumulation of R-loops and protects against transcription-replication collision events and DNA damage.

Lam F, Kong Y, Huang Q, Vu Han T, Maffa A, Kasper E Nat Commun. 2020; 11(1):4083.

PMID: 32796829 PMC: 7428008. DOI: 10.1038/s41467-020-17503-y.


Local delivery of dinutuximab from lyophilized silk fibroin foams for treatment of an orthotopic neuroblastoma model.

Ornell K, Taylor J, Zeki J, Ikegaki N, Shimada H, Coburn J Cancer Med. 2020; 9(8):2891-2903.

PMID: 32096344 PMC: 7163090. DOI: 10.1002/cam4.2936.


MYCN gene polymorphisms and Wilms tumor susceptibility in Chinese children.

Huang X, Zhao J, Zhu J, Chen S, Fu W, Tian X J Clin Lab Anal. 2019; 33(9):e22988.

PMID: 31343784 PMC: 7938399. DOI: 10.1002/jcla.22988.


Down-regulation of MYCN protein by CX-5461 leads to neuroblastoma tumor growth suppression.

Taylor J, Zeki J, Ornell K, Coburn J, Shimada H, Ikegaki N J Pediatr Surg. 2019; 54(6):1192-1197.

PMID: 30879743 PMC: 6545249. DOI: 10.1016/j.jpedsurg.2019.02.028.


References
1.
Kohler G, Milstein C . Continuous cultures of fused cells secreting antibody of predefined specificity. Nature. 1975; 256(5517):495-7. DOI: 10.1038/256495a0. View

2.
Slamon D, Boone T, Seeger R, Keith D, Chazin V, Lee H . Identification and characterization of the protein encoded by the human N-myc oncogene. Science. 1986; 232(4751):768-72. DOI: 10.1126/science.3008339. View

3.
Shulman M, Wilde C, Kohler G . A better cell line for making hybridomas secreting specific antibodies. Nature. 1978; 276(5685):269-70. DOI: 10.1038/276269a0. View

4.
White B, Bancroft F . Cytoplasmic dot hybridization. Simple analysis of relative mRNA levels in multiple small cell or tissue samples. J Biol Chem. 1982; 257(15):8569-72. View

5.
Vieira J, Messing J . The pUC plasmids, an M13mp7-derived system for insertion mutagenesis and sequencing with synthetic universal primers. Gene. 1982; 19(3):259-68. DOI: 10.1016/0378-1119(82)90015-4. View